The slip
PARKINSON RECEIPTno. 8838
24 Oct 2026, 17:03 UTCmicroglia, braak
predictionSIGLEC9 in microglia tracks Braak Lewy-body stage
registered066bc02e4f84e48b
discovery-0.16 p=0.685 n=9
replication-0.11 p=0.775 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.16, p 0.685)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT963bb4b940db56a8f102b6cb…
follows 8a3d8eb4550c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8838: SIGLEC9 in microglia, braak
- power
- full sample -0.09 (p 0.715, n 18), 95% CI -0.54 to +0.39. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.07 (p 0.774, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.13 (p 0.603, n 18). could be the mix.
- skeptic
- leave-one-out range -0.23 to +0.01, sign flips 3; without severely affected donors -0.09 (p 0.715, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SIGLEC9 in microglia.
case closed: nothing better to follow up.